Putative Breast Cancer Driver Mutations in TBX3 Cause Impaired Transcriptional Repression

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• TBX2 and TBX3 are T-box transcription factors frequently overexpressed in cancers like melanoma and breast cancer.
• Overexpression of TBX2/TBX3 promotes cancer progression by suppressing senescence and enhancing epithelial-mesenchymal transition.
• Conversely, loss of function in TBX3 and other T-box genes leads to developmental disorders.

Purpose of the Study:

• To investigate the functional impact of newly identified TBX3 mutations in breast cancer.
• To determine if these mutations confer gain-of-function or loss-of-function properties.
• To reconcile the role of TBX3 overexpression in tumorigenesis with observed mutations.

Main Methods:

• Exome sequencing of breast tumor samples to identify TBX3 mutations.
• In vitro DNA-binding assays for mutant TBX3 proteins.
• Cell culture experiments to assess target gene repression by mutant TBX3.
• In silico analysis of somatic TBX3 mutations using The Cancer Genome Atlas (TCGA) data.

Main Results:

• Five distinct mutations in the TBX3 DNA-binding T-domain were identified in breast tumors.
• Experimental and in silico analyses demonstrated that these mutations predominantly cause loss of TBX3 function.
• Mutant TBX3 proteins exhibited impaired DNA-binding and target gene repression capabilities.

Conclusions:

• The identified TBX3 mutations in breast cancer are largely non-functional.
• This suggests that the oncogenic role of TBX3 in breast cancer is primarily driven by its overexpression, not these specific mutations.
• Further research is needed to fully elucidate the complex role of TBX3 in cancer development.